background. Although hospital-acquired infections appear to be a growing threat to the survival of newborns in the developing world, the epidemiology of this problem remains poorly characterized.
Neonatal mortality accounts for more than one-third of all child deaths in the world each year. 1 Sepsis is a leading cause of death within the first month of life and is often acquired through vertical transmission or unhygienic care practices in healthcare facilities. [2] [3] [4] [5] [6] Hospital-acquired neonatal infection has emerged as a substantial health problem in developing areas. 3, 4, [7] [8] [9] Nosocomial infection due to multidrug-resistant strains of gram-negative rods (GNRs) appears to be a particular problem in some settings, but the extent of this problem remains poorly characterized.
We recently published the results of an interventional cohort study that combined epidemiologic surveillance for pathogen colonization with a package of infection control interventions at 2 neonatal intensive care units (NICUs) in Manila, the Philippines. 10 The primary analysis revealed a high frequency of colonization and bacteremia due to GNRs. 10 This analysis was conducted to characterize the epidemiology of these pathogens at the 2 NICUs.
methods
The epidemiologic survey was conducted from May 2003 through July 2004 at 2 NICUs in Manila, the Philippines: Philippines General Hospital and Jose Fabella Memorial Hospital. The hospital characteristics and study design are described elsewhere. 10 The study was approved by the institutional review boards of Boston University School of Medicine and Philippines General Hospital; neonates were enrolled if mothers provided informed consent. 
Laboratory Methods
We performed prospective, longitudinal surveillance for colonization with gentamicin-resistant GNRs or third-generation cephalosporin-resistant GNRs by means of stool cultures or perirectal surveillance cultures of samples collected on NICU days 0, 2, and 7 and weekly thereafter and on the day of discharge for all neonates hospitalized in the 2 NICUs. The laboratory methods and collection system are described elsewhere. 10 Blood samples for culture were collected for neonates with suspected sepsis, according to the clinical judgment of the NICU clinicians. In contrast with the colonization surveys, our reporting of GNR isolates identified in blood cultures was not limited to GNR isolates resistant to ceftazidime and/or gentamicin but included all GNR isolates.
All screening cultures were processed at the Philippines General Hospital microbiology research laboratory. Quality control procedures were established using standard drug-resistant and drug-susceptible strains of target pathogens (American Type Culture Collection; George Mason University Research Laboratory). Standard methods were used to obtain and analyze blood cultures. Positive cultures were referred to the research laboratory for confirmation and further characterization by means of the BACTEC blood culture system (Becton Dickinson).
Statistical Analyses
The primary outcome was the incidence density (the number of isolates per 100 patient-days at risk) of colonization with gentamicin-or third-generation cephalosporin-resistant GNRs or of bacteremia due to GNRs. Positive culture results for isolates of identical genus and species (and susceptibility) were counted only once, although a given infant could have provided data for more than 1 isolate if the isolates each had a different genus and species. We calculated the incidence densities for bacteremia and colonization independently of each other. To contrast incidence density between the 2 hospital NICUs, we calculated incidence rate ratios and corresponding 95% confidence intervals. Patients were censored at death or discharge from the NICUs. We conducted multivariate logistic regression analyses to calculate adjusted odds ratios with 95% confidence intervals of clinical variables. The variables included in the final model were hospital, sex, birth weight, gestational age, central venous catheter use, mechanical ventilation, and whether a given infant was colonized with gentamicin-or third-generation cephalosporin-resistant GNRs during the NICU stay. To estimate the percentage of GNR isolates that would be susceptible to a given antibiotic if used as empirical therapy, we calculated a weighted average of the percentage of GNR isolates that would be effectively treated by each antibiotic. This factored in the relative frequency of each pathogen that caused sepsis within our data set, multiplied by the percentage that was susceptible to a given antibiotic. All analyses were performed with SAS, version 9.2 (SAS), and Excel (Microsoft).
results Table 1 describes the clinical characteristics of the neonates in our study. A total of 1,831 neonates were enrolled at both a Total no. of isolates is higher than total no. of infants because some infants were colonized or bacteremic with 11 pathogen.
NICUs during the study period ( Table 1) . Most of the neonates were admitted with low birth weight and prematurity. Seven hundred sixty-nine (83%) of 926 neonates at Philippines General Hospital and 633 (70%) of 905 neonates at Jose Fabella Memorial Hospital were admitted directly from the labor and delivery ward on the calendar day of their birth. There were statistically significant differences in the use of invasive devices between the 2 NICUs: the percentage of newborns who had central venous catheters or were mechanically ventilated was higher at Jose Fabella Memorial Hospital than at Philippines General Hospital. The cumulative incidence of colonization with drug-resistant GNRs and the cumulative incidence of bacteremia due to GNRs are shown in Table 2 . Surveillance cultures yielded a total of 1,997 drug-resistant GNRs. There were 358 newborns who became bacteremic with a total of 437 GNRs. More than half (1,017 [55.5%]) of the neonates became colonized with drug-resistant GNRs during their NICU hospitalization, and nearly 20% (358 [19.6%]) had a blood culture positive for GNRs. The most common GNRs identified in both colonizing and invasive isolates were Klebsiella species, Pseudomonas aeruginosa, and Enterobacter species. In addition, a high percentage of colonization and bacteremia (76.0% and 34.3%, respectively) at the 2 NICUs was caused by nonenteric GNRs. Table 3 summarizes data about the GNRs identified in blood cultures and their antibiotic susceptibility profiles. Among the most common pathogens isolated, multidrug resistance was the rule rather than the exception. For example, the majority of Klebsiella isolates were resistant to ampicillin/ sulbactam, ceftazidime, gentamicin and tobramycin, with nearly half of the Enterobacter isolates also being resistant to amikacin. Resistance rates were even higher among the common nonenteric GNRs, with approximately 70% of P. aeruginosa isolates resistant to 7 of the 9 classes of antibiotics tested. In fact, the only agent with reliable activity against P. aeruginosa was piperacillin-tazobactam, and even with this agent, 20% of the isolates were resistant. The most consis- tently active antibiotics, given the spectrum of pathogens encountered, were imipenem, piperacillin/tazobactam, and cefepime, but none of these would have reliably covered the full spectrum of pathogens that caused sepsis in this population. Conversely, ampicillin/sulbactam, gentamicin, tobramycin, and trimethoprim-sulfamethoxazole showed unacceptably low rates of activity against all of the isolates tested.
To better characterize the rates of colonization and bacteremia with drug-resistant GNRs by controlling for patient exposure time at risk, we calculated incidence densities for drug-resistant GNRs. Because a high proportion of isolates were nonenteric GNRs, such as P. aeruginosa, the analyses were stratified into enteric and nonenteric GNRs. Table 4 summarizes the incidence densities and incidence rate ratios for each NICU. As expected, incidence densities for colonization were far higher than those for bacteremia and particularly high at Jose Fabella Memorial Hospital. Table  5 shows the adjusted and unadjusted odds ratios for the occurrence of bacteremia. Not surprisingly, the factor associated with the highest risk of bacteremia was being at the Jose Fabella Memorial Hospital NICU. Of the patient characteristics, gestational age less than 29 weeks was a significant risk factor for bacteremia. Additionally, birth weights of 1,500-2,000 g and 1,000-1,499 g were both associated with increased risk for sepsis in univariate analysis. However, after multivariate adjustments, these risks vanished, and the risk associated with prematurity increased further. The incidence density of sepsis in extremely low-birth-weight (!1,000 g) infants remained significantly lower compared with the higherweight category newborns (1.1 sepsis episodes per 100 patient-days for infants of birth weight !1,000 g vs 3.8 sepsis episodes per 100 patient-days for infants of birth weight x2,500 g; ), despite the paradoxically associated re-P ! .05 duced odds of invasive disease.
discussion
We identified an alarming burden of drug-resistant GNRs at these 2 NICUs in the Philippines. The majority of neonates in our study rapidly became colonized with drug-resistant GNRs, and sepsis caused by these pathogens and confirmed by blood culture results was highly prevalent. A high proportion of these pathogens represented bacteria typically understood to be environmental organisms; this fact suggests that the source of these pathogens was not maternal transfer during delivery but more likely nosocomial spread of organisms through poor infection control. Infrequent hand washing, inadequate equipment cleaning, and other unhygienic care practices in medical facilities all aid the transfer of nosocomial pathogens. [2] [3] [4] [5] [6] Our study revealed that premature and low-birth-weight infants, particularly those requiring mechanical ventilation, were at increased risk of invasive disease.
The high burden of infection and the degree of antibiotic resistance seen in our study population may signify an emerging trend among sepsis isolates recovered from neonates in NICUs in developing countries. In a review of data from developing countries, Zaidi et al. 9 found rates of neonatal infection in hospitalized infants to be 3-20 times higher than those in developed countries, and approximately 70% of these infections would not be susceptible to conventional empirical antibiotic regimens, such as ampicillin with gentamicin. There is also evidence of emerging resistance to third-generation cephalosporins and quinolones. 8 A myriad of problems result: the inability to adequately treat infection caused by these organisms is likely linked to the high rates of morbidity and mortality at these units, the use of broad-spectrum antibiotics is expensive, these pathogens can spread to other patients, and the need to empirically use broad-spectrum antibiotics can itself further contribute to an epidemic of multidrugresistant pathogens within units. [11] [12] [13] [14] [15] We were unable to explain the paradoxical association between extremely low birth weight and rates of sepsis. This oddity may reflect residual confounding, the small number of subjects, or uncertainties with regard to the direction of causality. An additional possibility is that this group is more likely to die of causes other than sepsis, such as lung prematurity or necrotizing enterocolitis. Unfortunately, without cause-of-death data for the infants, we could not test this hypothesis.
In conclusion, we encountered high rates of colonization and bacteremia with drug-resistant GNRs in 2 NICUs in the Philippines. As neonatal intensive care becomes more readily available in resource-poor countries, improved infection control practices are an absolute necessity. Empirical antibiotic therapy for treatment of neonatal sepsis should be adjusted according to local surveillance and susceptibility data, potentially even within different wards of a given institution. However, given the extent to which drug-resistant pathogens have already become an important cause of neonatal sepsis, the interruption of the transmission of these pathogens through improved infection control techniques must be a priority.
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